iRhythm Technologies, Inc. NASDAQ:IRTC

iRhythm Technologies stock price today

$158.22
+69.42
+78.18%
Financial Health
0
1
2
3
4
5
6
7
8
9

iRhythm Technologies stock price monthly change

-7.68%
month

iRhythm Technologies stock price quarterly change

-7.68%
quarter

iRhythm Technologies stock price yearly change

-18.54%
year

iRhythm Technologies key metrics

Market Cap
2.74B
Enterprise value
4.05B
P/E
-34.23
EV/Sales
9.87
EV/EBITDA
-44.03
Price/Sales
9.74
Price/Book
16.70
PEG ratio
2.81
EPS
-4.23
Revenue
513.17M
EBITDA
-91.27M
Income
-129.96M
Revenue Q/Q
18.38%
Revenue Y/Y
19.34%
Profit margin
-28.27%
Oper. margin
-21.21%
Gross margin
68.54%
EBIT margin
-21.21%
EBITDA margin
-17.79%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

iRhythm Technologies stock price history

iRhythm Technologies stock forecast

iRhythm Technologies financial statements

Average Price Target
Last Year

$108.11

Potential downside: -31.67%

Based on estimate of 8 analysts
  • Analysts Price target

  • Financials & Ratios estimates

iRhythm Technologies, Inc. (NASDAQ:IRTC): Profit margin
Jun 2023 124.13M -18.48M -14.89%
Sep 2023 124.60M -27.11M -21.76%
Dec 2023 132.51M -38.69M -29.2%
Mar 2024 131.92M -45.66M -34.61%
iRhythm Technologies, Inc. (NASDAQ:IRTC): Debt to assets
Jun 2023 429488000 205.60M 47.87%
Sep 2023 439769000 219.97M 50.02%
Dec 2023 433144000 223.04M 51.49%
Mar 2024 909755000 819.46M 90.08%
iRhythm Technologies, Inc. (NASDAQ:IRTC): Cash Flow
Jun 2023 -4.57M 9.00M 4.38M
Sep 2023 1.19M -15.43M 66K
Dec 2023 -15.97M 1.4M 3.46M
Mar 2024 -52.02M 39.99M 504.64M

iRhythm Technologies alternative data

iRhythm Technologies, Inc. (NASDAQ:IRTC): Employee count
Aug 2023 1,793
Sep 2023 1,793
Oct 2023 1,793
Nov 2023 1,793
Dec 2023 1,793
Jan 2024 1,793
Feb 2024 1,793
Mar 2024 2,000
Apr 2024 2,000
May 2024 2,000
Jun 2024 2,000
Jul 2024 2,000

iRhythm Technologies other data

91.21% -8.79%
of IRTC is owned by hedge funds
27.22M -2.48M
shares is hold by hedge funds

iRhythm Technologies, Inc. (NASDAQ:IRTC): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 7218
Feb 2024 0 35052
Mar 2024 0 15590
Jun 2024 0 1641
Jul 2024 0 1404
Aug 2024 0 5072
Nov 2024 6664 16145
Dec 2024 0 2492
Transaction Date Insider Security Shares Price per share Total value Source
Sale
MURPHY PATRICK MICHAEL officer: CBO and CLO
Common Stock 2,492 $85.89 $214,038
Purchase
TALWALKAR ABHIJIT Y director
Common Stock 6,664 $75.16 $500,866
Sale
BLACKFORD QUENTIN S. director, officer: President an..
Common Stock 16,145 $77.41 $1,249,784
Sale
BOBZIEN BRICE officer: Chief Financial Officer
Common Stock 1,372 $70.34 $96,506
Sale
PATTERSON CHAD officer: Chief Commercial Officer
Common Stock 3,012 $74.66 $224,876
Sale
SMITH MERVIN officer: EVP Strategic Business..
Common Stock 688 $74.66 $51,366
Sale
TURAKHIA MINANG officer: EVP, CMO & CSO
Common Stock 1,404 $105.65 $148,333
Sale
ROSENBAUM MARC W. officer: Chief Accounting Officer
Common Stock 510 $88.91 $45,344
Sale
SHRISHRIMAL SUMI officer: EVP, Chief Risk Officer
Common Stock 1,131 $88.91 $100,557
Sale
DAY MARK J. officer: Chief Te.. Common Stock 3,248 $111.14 $360,983
Patent
Grant
Filling date: 14 Feb 2022 Issue date: 12 Jul 2022
Grant
Filling date: 18 Feb 2022 Issue date: 5 Jul 2022
Grant
Filling date: 6 Aug 2021 Issue date: 7 Jun 2022
Grant
Filling date: 6 Aug 2021 Issue date: 7 Jun 2022
Application
Filling date: 18 Feb 2022 Issue date: 2 Jun 2022
Application
Filling date: 14 Feb 2022 Issue date: 26 May 2022
Grant
Filling date: 6 Aug 2021 Issue date: 24 May 2022
Grant
Filling date: 7 Dec 2021 Issue date: 29 Mar 2022
Application
Filling date: 7 Dec 2021 Issue date: 24 Mar 2022
Grant
Filling date: 9 Aug 2021 Issue date: 22 Feb 2022
Sunday, 29 December 2024
accesswire.com
Thursday, 26 December 2024
accesswire.com
Sunday, 22 December 2024
accesswire.com
Wednesday, 18 December 2024
accesswire.com
Sunday, 15 December 2024
accesswire.com
Friday, 13 December 2024
marketbeat.com
Wednesday, 11 December 2024
accesswire.com
Tuesday, 3 December 2024
https://thefly.com
Wednesday, 20 November 2024
globenewswire.com
Monday, 18 November 2024
globenewswire.com
Tuesday, 5 November 2024
globenewswire.com
Friday, 1 November 2024
globenewswire.com
Wednesday, 30 October 2024
seekingalpha.com
zacks.com
globenewswire.com
globenewswire.com
Monday, 28 October 2024
globenewswire.com
Wednesday, 23 October 2024
zacks.com
Tuesday, 22 October 2024
benzinga.com
zacks.com
Monday, 21 October 2024
globenewswire.com
Wednesday, 16 October 2024
globenewswire.com
Friday, 20 September 2024
globenewswire.com
Friday, 13 September 2024
zacks.com
Wednesday, 11 September 2024
globenewswire.com
Tuesday, 10 September 2024
zacks.com
Monday, 9 September 2024
zacks.com
globenewswire.com
Sunday, 1 September 2024
globenewswire.com
Friday, 30 August 2024
zacks.com
  • What's the price of iRhythm Technologies stock today?

    One share of iRhythm Technologies stock can currently be purchased for approximately $158.22.

  • When is iRhythm Technologies's next earnings date?

    Unfortunately, iRhythm Technologies's (IRTC) next earnings date is currently unknown.

  • Does iRhythm Technologies pay dividends?

    No, iRhythm Technologies does not pay dividends.

  • How much money does iRhythm Technologies make?

    iRhythm Technologies has a market capitalization of 2.74B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 19.9% to 492.68M US dollars.

  • What is iRhythm Technologies's stock symbol?

    iRhythm Technologies, Inc. is traded on the NASDAQ under the ticker symbol "IRTC".

  • What is iRhythm Technologies's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of iRhythm Technologies?

    Shares of iRhythm Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are iRhythm Technologies's key executives?

    iRhythm Technologies's management team includes the following people:

    • Mr. Kevin M. King Consultant & Director(age: 69, pay: $1,390,000)
    • Mr. Douglas J. Devine Chief Operating Officer, Chief Financial Officer & Sec.(age: 55, pay: $573,160)
    • Mr. David A. Vort Executive Vice President of Sales & Chief Commercial Officer(age: 59, pay: $552,100)
    • Mr. Mark J. Day Ph.D. Executive Vice President of R&D(age: 54, pay: $538,430)
  • How many employees does iRhythm Technologies have?

    As Jul 2024, iRhythm Technologies employs 2,000 workers.

  • When iRhythm Technologies went public?

    iRhythm Technologies, Inc. is publicly traded company for more then 8 years since IPO on 20 Oct 2016.

  • What is iRhythm Technologies's official website?

    The official website for iRhythm Technologies is irhythmtech.com.

  • Where are iRhythm Technologies's headquarters?

    iRhythm Technologies is headquartered at 699 8th Street, San Francisco, CA.

  • How can i contact iRhythm Technologies?

    iRhythm Technologies's mailing address is 699 8th Street, San Francisco, CA and company can be reached via phone at +41 56325700.

  • What is iRhythm Technologies stock forecast & price target?

    Based on 8 Wall Street analysts` predicted price targets for iRhythm Technologies in the last 12 months, the avarage price target is $108.11. The average price target represents a -31.67% change from the last price of $158.22.

iRhythm Technologies company profile:

iRhythm Technologies, Inc.

irhythmtech.com
Exchange:

NASDAQ

Full time employees:

2,000

Industry:

Medical - Devices

Sector:

Healthcare

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

699 8th Street
San Francisco, CA 94103

CIK: 0001388658
ISIN: US4500561067
CUSIP: 450056106